Clinical Trial Update: Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated docetaxel in patients with stage II or stage III prostate cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED